Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.22 USD
0.00 (2.23%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $0.22 0.00 (-1.96%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
VIRX 0.22 0.00(2.23%)
Will VIRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VIRX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VIRX
Here's Why Sunesis (VIRX) Is a Great 'Buy the Bottom' Stock Now
Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?
VIRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Sunesis (VIRX) Have the Potential to Rally 335% as Wall Street Analysts Expect?
Viracta (VIRX) Up on Orphan Drug Tag for Peripheral Lymphoma
Other News for VIRX
Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Viracta Therapeutics price target lowered by $2 at RBC Capital, here's why
Viracta Therapeutics just downgraded at Leerink, here's why
VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024
Sunesis: Q2 Earnings Snapshot